Latest News  

FDA Approves Adalimumab-atto, a Biosimilar of Humira

WASHINGTON (Reuters)—The U.S. Food and Drug Administration on Friday approved a cheaper, biosimilar version of AbbVie’s top-selling arthritis drug, adalimumab (Humira). The drug, adalimumab-atto (Amjevita),… [Read More]

How to Thrive—Not Just Survive—as a New Manager, Part 1

The transition from employee to manager in a rheumatology practice can be daunting. But according to experts, setting clear roles and responsibilities and cultivating professional relationships with your employees ultimately help make you and the practice successful… [Read More]

Celltrion Accelerates U.S. Launch of Infliximab-dyyb, a Remicade Biosimilar

After winning the initial patent infringement lawsuit filed by Janssen, Celltrion Inc. is now shipping Inflectra (infliximab-dyyb), a biosimilar of Remicade (infliximab), to the U.S… [Read More]

Is Arthroscopic Meniscal Surgery Effective?

A recent review examined the effectiveness of arthroscopic mensical surgery in treating meniscal injuries. Researchers determined that little evidence exists to support the use of arthroscopic meniscal surgery and more studies that directly compare it with nonoperative treatments are needed… [Read More]

Novel Astrocytic Autoantibody Associated with Relapsing Meningoencephalomyelitis

NEW YORK (Reuters Health)—An autoantibody to glial fibrillary acidic protein (GFAP) is associated with relapsing autoimmune meningoencephalomyelitis that is responsive to immunotherapy, researchers report. “Autoimmune… [Read More]

U.S. Justice Department to Push Prosecutors on Opioids

WASHINGTON (Reuters)—The U.S. Justice Department will enlist federal prosecutors to help fight the nation’s opioid crisis by sharing information on overprescribing doctors and coordinating with… [Read More]

View More Latest News »